|
Saladax is a pharmacodiagnostic company dedicated to the development of innovative patented immunoassays to simply and accurately measure chemotherapy blood levels. These developing technologies will provide oncologists with a new standard of care to balance efficacy against side effects thereby reducing toxicity, improving outcomes, and lowering cancer-care costs. To help communicate and educate these goals and breakthroughs, KGGD partnered with Saladax to develop a series of trade show exhibits as well as a family of brochures that were translated into multiple languages to extend the reach of their messaging. |
|
|